New rinse aims to cut infection risk in spine surgery

NCT ID NCT07667036

Not yet recruiting Prevention Sponsor: Universität Luzern Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 30, 2026 · Updated 3 times

Summary

This study tests whether rinsing the surgical wound with a solution called PREVENTIA (polyhexanide and poloxamer) during spinal fusion surgery can reduce bacteria in the wound. About 114 adults having elective spine surgery will be randomly assigned to receive either the special rinse or a standard saltwater rinse. The main goal is to see if the special rinse lowers the number of bacteria found on swabs taken during the operation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Polyhexanide-poloxamer solution (PREVENTIA)
What this could lead to: If it works, this could provide a simple way to lower infection risk in spine surgeries, reducing complications and recovery time.
What could go wrong: This is a small, early-phase trial (114 people) testing only bacterial reduction, not actual infection rates. The rinse may not prevent infections in practice, and results may not apply to all spine surgeries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINE SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Surgical Wound Infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SPINE SURGERY SURGICAL SITE INFECTION (SSI) SURGICAL SITE INFECTION PREVENTION

Contacts and locations

Locations

Hirslanden Klinik St. Anna

Lucerne, 6006, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.